Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis

BACKGROUND: In adult patients with arthritis, use of the tumor necrosis factor (TNF) inhibitor etanercept (ETN) is often associated with a reduction in the utilization of co-medications, particularly steroids. Comparatively little is known about the utilization of co-medications when ETN is initiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Khraishi, Majed, Millson, Brad, Woolcott, John, Jones, Heather, Marshall, Lisa, Ruperto, Nicolino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734296/
https://www.ncbi.nlm.nih.gov/pubmed/31500631
http://dx.doi.org/10.1186/s12969-019-0358-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734296/
https://www.ncbi.nlm.nih.gov/pubmed/31500631
http://dx.doi.org/10.1186/s12969-019-0358-x

Ejemplares similares